Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies
DiscussionPopulation-based evidence for other SGAs and metabolic outcomes was limited. However, clozapine and olanzapine were consistently more strongly associated with metabolic adverse events than were other SGAs currently available.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Hypertension | Metabolic Syndrome | Obesity | Risperdal Consta | Seroquel | Study | Zyprexa